A microRNA panel that regulates proinflammatory cytokines as diagnostic and prognosis biomarkers in colon cancer

Antonio Martínez-Gutierrez, Berenice Carbajal-Lopez, Triet M. Bui, Monica Mendoza-Rodriguez, Alma D. Campos-Parra, Germán Calderillo-Ruiz, David Cantú-De Leon, Eduardo Osiris Madrigal-Santillán, Ronen Sumagin, Carlos Pérez-Plasencia*, Eloy Andrés Pérez-Yépez*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Colon cancer (CC) is the third most common neoplasm and the fourth cause of cancer-related death worldwide in both sexes. It has been established that inflammation plays a critical role in tumorigenesis and progression of CC. Immune, stromal and tumor cells supply the tumor microenvironment with pro-inflammatory cytokines such as interleukin 1β, TNFα, IL-6 and IL-11, to hyperactivate signaling pathways linked to cancerous processes. Recent findings suggest a putative role of microRNAs (miRNAs) in the progression and management of the inflammatory response in intestinal diseases. Moreover, miRNAs are able to regulate expression of molecular mediators that are linking inflammation and cancer. In this work a miRNA panel differentially expressed between healthy, inflammatory bowel disease (IBD) and CC tissue was established. Identified miRNAs regulate signaling pathways related to inflammation and cancer progression. An inflammation associated-miRNA panel composed of 11-miRNAs was found to be overexpressed in CC but not in inflamed or normal tissues (miR-21-5p, miR-304-5p, miR-577, miR-335-5p, miR-21-3p, miR-27b-5p, miR-335-3p, miR-215-5p, miR-30b-5p, miR-192-5p, miR-3065-5p). The association of top hit miRNAs, miR-3065-5p and miR-30b-5p expression with overall survival of CC patients was demonstrated using Kaplan-Meier tests. Finally, differential miRNA expression was validated using an inflammation-associated CC model induced by Azoxymethane/Dextran Sodium Sulfate (AOM/DSS) to compare miRNA expression in normal and inflamed tissue versus CC tissues. Based on these findings we propose the identified inflammatory miRNA panel as a potent diagnostic tool for CC determination.

Original languageEnglish (US)
Article number101252
JournalBiochemistry and Biophysics Reports
StatePublished - Jul 2022


  • Biomarkers
  • Colon cancer
  • Computational assay
  • Proinflammatory cytokines

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Cell Biology


Dive into the research topics of 'A microRNA panel that regulates proinflammatory cytokines as diagnostic and prognosis biomarkers in colon cancer'. Together they form a unique fingerprint.

Cite this